hiPSC-Derived Cardiomyocyte Model of LQT2 Syndrome Derived from Asymptomatic and Symptomatic Mutation Carriers Reproduces Clinical Differences in Aggregates but Not in Single Cells
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Mutations in the HERG gene encoding the potassium ion channel HERG, represent one of the most frequent causes of long QT syndrome type-2 (LQT2). The same genetic mutation frequently presents different clinical phenotypes in the family. Our study aimed to model LQT2 and study functional differences between the mutation carriers of variable clinical phenotypes. We derived human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) from asymptomatic and symptomatic HERG mutation carriers from the same family. When comparing asymptomatic and symptomatic single LQT2 hiPSC-CMs, results from allelic imbalance, potassium current density, and arrhythmicity on adrenaline exposure were similar, but a difference in Ca2+ transients was observed. The major differences were, however, observed at aggregate level with increased susceptibility to arrhythmias on exposure to adrenaline or potassium channel blockers on CM aggregates derived from the symptomatic individual. The effect of this mutation was modeled in-silico which indicated the reactivation of an inward calcium current as one of the main causes of arrhythmia. Our in-vitro hiPSC-CM model recapitulated major phenotype characteristics observed in LQT2 mutation carriers and strong phenotype differences between LQT2 asymptomatic vs. symptomatic were revealed at CM-aggregate level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Traditionally, animal models, primary cells, embryonic stem cells (ESC), and immortalized cell lines derived from tumor cells are used to model a variety of human diseases [8,9,10,11].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Type-2 LQTS patients’ iPSC-derived cardiomyocytes showed that a mutation in KCNH2 causes action-potential-duration prolongation by reducing the cardiac potassium current IKr and dysfunction of the sodium ion channel [7,8,9].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [9]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Curran, M. E., Splawski, I., Timothy, K. W., Vincen, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,259 · cited 1×
“LQT2 is a channelopathy with a mutation in the HERG gene on chromosome 7 [9,10].”
BackgroundAl-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,854
Schwartz, P. J., Priori, S. G., Spazzolini, C., Moss, A. J., Vincent, G. M., Napolitano, C., Denjoy, I., Guicheney, P., Breithardt, G., Keating, M. T., et al. (2001) · Circulation · doi:10.1161/01.cir.103.1.89 · Cited by 1,779
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251 · cited 2×
“The expression ratios of HERG Finnish founder mutation (FinA) (p.L552S mutation) and HERG-wild type (WT) alleles were determined by plasmid-derived standard curve method (Moretti et al. 2010).”
BackgroundMethodSpectrum of Mutations in Long-QT Syndrome Genes: KVLQT1 , HERG , SCN5A , KCNE1 , and KCNE2
Splawski, I., Shen, J., Timothy, K. W., Lehmann, M. H., Priori, S., Robinson, J. L., Moss, A. J., Schwartz, P. J., Towbin, J. A., Vincent, G. M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1178 · Cited by 1,231
Prevalence of the Congenital Long-QT Syndrome
Schwartz, P. J., Stramba-Badiale, M., Crotti, L., Pedrazzini, M., Besana, A., Bosi, G., Gabbarini, F., Goulene, K., Insolia, R., Mannarino, S., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.863209 · Cited by 1,072
Modelling the long QT syndrome with induced pluripotent stem cells
Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., et al. (2011) · Nature · doi:10.1038/nature09747 · Cited by 1,049 · cited 1×
“Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have been shown to recapitulate disease phenotypes of inherited cardiac diseases such as long QT syndrome and catecholamine polymorphic ventricular tachycardia (CPVT) [24–29].”
BackgroundAl-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000549 · Cited by 724
Mummery, C. L., Zhang, J., Ng, E. S., Elliott, D. A., Elefanty, A. G., & Kamp, T. J. (2012) · Circulation Research · doi:10.1161/circresaha.110.227512 · Cited by 713 · cited 1×
“Human-induced pluripotent stem cells (hiPSCs) were di (cid:11) erentiated into CMs by the mouse endoderm-like cell line END-2 co-culture method [32] on mouse embryonic fibroblast (MEF) feeder cells (CellSystems, Troisdorf, Germany).”
MethodAl-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.036 · Cited by 629
Cited by
Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy
Nicholson, M. W., Ting, C.-Y., Chan, D. Z. H., Cheng, Y.-C., Lee, Y.-C., Hsu, C.-C., Huang, C.-Y., & Hsieh, P. C. H. (2022) · Cells · doi:10.3390/cells11111853 · Cited by 65
Stem Cell-Based Disease Modeling and Cell Therapy
Bai, X. (2020) · Cells · doi:10.3390/cells9102193 · Cited by 36
Long QT syndrome – Bench to bedside
Ponce‐Balbuena, D., & Deschênes, I. (2021) · Heart Rhythm O2 · doi:10.1016/j.hroo.2021.01.006 · Cited by 32
Arrhythmia Mechanisms in Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
Paci, M., Penttinen, K., Pekkanen-Mattila, M., & Koivumäki, J. T. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000972 · Cited by 26
Self-citationData analytics for cardiac diseases
Juhola, M., Joutsijoki, H., Penttinen, K., Shah, D. A., Pölönen, R.-P., & Aalto‐Setälä, K. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105218 · Cited by 26
Self-citationhERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation
Chang, Y., Li, Y., Bai, R., Wu, F., Ma, S., Saleem, A., Zhang, S., Jiang, Y., Dong, T., Guo, T., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02346-1 · Cited by 18
Multifactorial approaches to enhance maturation of human iPSC-derived cardiomyocytes
Kistamás, K., Müller, A., Muenthaisong, S., Lamberto, F., Zana, M., Dulac, M., Leal, F., Maziz, A., Costa, P. F., Bernotienė, E., et al. (2023) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2023.122668 · Cited by 17
From Human Pluripotent Stem Cells to 3D Cardiac Microtissues: Progress, Applications and Challenges
Branco, M. A., Cabral, J. M. S., & Diogo, M. M. (2020) · Bioengineering · doi:10.3390/bioengineering7030092 · Cited by 11
Stem Cell Studies in Cardiovascular Biology and Medicine: A Possible Key Role of Macrophages
Kawaguchi, N., & Nakanishi, T. (2022) · Biology · doi:10.3390/biology11010122 · Cited by 13
Morpho-functional comparison of differentiation protocols to create iPSC-derived cardiomyocytes
Nijak, A., Simons, E., Vandendriessche, B., de Sande, D. V. V., Fransén, E., Sieliwończyk, E., Gucht, I. V., Craenenbroeck, E. M. V., Saenen, J. B., Heidbüchel, H., et al. (2022) · Biology Open · doi:10.1242/bio.059016 · Cited by 10
Bortoli, M. D., Meraviglia, V., Macková, K., Frommelt, L. S., König, E., Rainer, J., Volani, C., Benzoni, P., Schlittler, M., Cattelan, G., et al. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.02.029 · Cited by 10
“hiPSC-derived retinal ganglion cells (hiPSC-RGCs) and hiPSC derived neural crest cells (hiPSC-NCCs), including autonomic and sensory neurons, have been successfully used to investigate reduced penetrance and variable expressivity, identifying different genetic modifiers in long QT Syndrome [24], [25], [26], [27], Lebe…”
BackgroundMethodOn computational classification of genetic cardiac diseases applying iPSC cardiomyocytes
Juhola, M., Joutsijoki, H., Penttinen, K., Shah, D. A., & Aalto‐Setälä, K. (2021) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2021.106367 · Cited by 10
Self-citationA need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
Alameh, M., Oliveira-Mendes, B. B. R., Kyndt, F., Rivron, J., Denjoy, I., Lesage, F., Schott, J., WAARD, M. M. D., & Loussouarn, G. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1132533 · Cited by 9
“In order to mimic as much as possible, the condition of the patient, it is useful 1) to determine if there is an equal expression of both alleles, which seems to be the case (Shah et al., 2020), and 2) to be able to reproduce in the model of study this equal expression of both alleles.”
ResultPenttinen, K., Prajapati, C., Shah, D. A., Rajan, D. K., Cherian, R. M., Swan, H., & Aalto‐Setälä, K. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03234-7 · Cited by 8
Self-citationWu, H., Hamilton, C., Porritt, H., Winbo, A., & Zeltner, N. (2024) · The Journal of Physiology · doi:10.1113/jp286416 · Cited by 7
“…these techniques, using hiPSC-CMs with KCNH2 gene variants re-creating the LQT2 phenotype, which exhibits a prolonged cardiac action potential, increased afterdepolarization frequency and reduced rapid rectifier potassium current (IKr) (Itzhaki et al., 2011; Matsa et al., 2011; Shah et al., 2020).”
Zhang, Y., Huang, G., Yuan, Z., Zhang, Y., & Chang, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.760515 · Cited by 7
“…symptomatic individuals with LQT2 differs in the level of CM aggregation; an increase in arrhythmia is observed in symptomatic hiPSC-CM, which makes it convenient for us to use hiPSC-CM to observe the different phenotypes of mutation carriers with different clinical phenotypes (Shah et al., 2020).”
MethodTranslational potential of hiPSCs in predictive modeling of heart development and disease
Mansfield, C., Zhao, M., & Basu, M. (2022) · Birth Defects Research · doi:10.1002/bdr2.1999 · Cited by 6
van den Brink, L., Brandão, K. O., Yiangou, L., Blanch-Asensio, A., Mol, M. P. H., Mummery, C. L., Verkerk, A. O., & Davis, R. P. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.755642 · Cited by 5
“We and others have previously shown that performing electrophysiological measurements in such multicellular format enables differences in disease phenotype to be detected in hiPSC-CM models of LQT2 that were not uncovered in single cardiomyocytes (Brandão et al., 2020; Shah et al., 2020).”
BackgroundA method to measure data complexity of a complicated medical data set
Juhola, M., Joutsijoki, H., Penttinen, K., Shah, D. A., & Aalto‐Setälä, K. (2022) · International Journal of Imaging Systems and Technology · doi:10.1002/ima.22760 · Cited by 5
“derivative maximum of the left side, location for (6) absolute first”
BackgroundSelf-citationArtificial intelligence for Brugada syndrome diagnosis and gene variants interpretation
Sahebnasagh, M., & Farjoo, M. H. (2025) · American Journal of Cardiovascular Disease · doi:10.62347/yqhq1079 · Cited by 4
Optical Mapping in hiPSC-CM and Zebrafish to Resolve Cardiac Arrhythmias
Vandendriessche, B., Sieliwończyk, E., Alaerts, M., Loeys, B., Snyders, D. J., & Schepers, D. (2020) · Hearts · doi:10.3390/hearts1030018 · Cited by 4
Forouzandehmehr, M., Cogno, N., Koivumäki, J. T., Hyttinen, J., & Paci, M. (2020) · Computing in cardiology · doi:10.22489/cinc.2020.055 · Cited by 2
Self-citationZheng, B., Zhu, Y., Sun, M., Cheng, H., Zhang, S., Cai, C., Gu, K., An, Y., Ding, X., Zhang, F., et al. (2026) · Heart Rhythm O2 · doi:10.1016/j.hroo.2025.12.022 · Cited by 2
“…studies validating long QT-specific iPSC-CMs have observed afterdepolarizations, which are commonly associated with triggered activity in LQTS. 30,31 However, in our study, we did not observe this phenomenon, which aligns with clinical observations that patients with LQTS2 require additional…”
Pesu, E., Kuusela, E., Moilanen, A.-M., Vinogradov, A., Tornberg, K., Lappi, H., Sukki, L., Ryynänen, T., Salpavaara, T., Kapucu, F. E., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-62182-2 · Cited by 1
Self-citationFollin, B., Caluori, G., Dobrolińska, M. M., Stachura, J., Muzzamil, H., Wojakowski, W., Qayyum, A. A., & Jadczyk, T. (2023) · Springer eBooks · doi:10.1007/978-981-99-0722-9_3
Experimental models and model organisms in cardiac electrophysiology: Opportunities and challenges
(2023) · Frontiers research topics · doi:10.3389/978-2-8325-3523-3
Torsades de pointe : implications de l’axe neuro-cardiaque
Goual, L., Bounasri, E., Guennec, J. L., & Thireau, J. (2024) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/j.amcp.2024.09.005
Phénotypage à haut débit des variants du canal potassique cardiaque hERG.
Alameh, M. (2024) · theses.fr (ABES) · doi:10.70675/382eef7az2f22z4e15z9fd6z35977881140a
Penttinen, K., Prajapati, C., Shah, D. A., Rajan, D. K., Cherian, R. M., Swan, H., & Aalto-Setälä, K. (2024) · Figshare · doi:10.6084/m9.figshare.26584890
Self-citationDeBose, M., Ding, D., Griggs, A., Harbuzariu, A., & Itzhaki, I. (2026) · Stem Cell Research · doi:10.1016/j.scr.2026.103951
Research progress on the relationship between long QT syndrome (LQTS) and epilepsy: A review
Li, Q., & Meng, L.-B. (2026) · Medicine · doi:10.1097/md.0000000000048282
“[46,47] 50] This subunit is expressed in various tissues, including the heart and brain, causing abnormal repolarization in the heart and an epileptic phenotype.”
Li, Q., Guo, C.-T., Ren, J.-C., Wang, Y., Zhao, Z.-J., Lv, C.-H., Wang, Q.-Y., Liu, Q., Лі, К., Yang, J., et al. (2026) · World Journal of Stem Cells · doi:10.4252/wjsc.v18.i5.117584
Fakiyesi, T. T., Ozioko, M., Ogunseye, O., Adeyemi, O., Adedoyin, I., Badejo, A. A., Anifalaje, O. K., Adegbesan, A., Olalude, O. E., Tiamiyu, R. T., et al. (2026) · Cureus · doi:10.7759/cureus.116111
“This has improved the understanding of mutation-specific disease and medication responses in catecholaminergic polymorphic ventricular tachycardia (CPVT) and other channelopathies [74].”
Huynh, T., Ye, D., Zhou, W., Tester, D. J., Garmany, R., Giudicessi, J. R., & Ackerman, M. J. (2026) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.126.014919
Metadata
- Authors
- Shah, D., Prajapati, C., Penttinen, K., Cherian, R. M., Koivumäki, J. T., Alexanova, A., Hyttinen, J., & Aalto-Setälä, K.
- Affiliations
- Tampere University (FI)
- Faculty of Medicine and Health Technology and BioMediTech Institute, Tampere University, 33520 Tampere, Finland
- Corresponding author
- Shah, Disheet
- ORCID
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-05-07
- Volume
- 9
- Issue
- 5
- Pages
- 1153
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7290503
- OpenAlex
- W3020941314
- Cited by
- 31
- References
- 57
- Citations by year
- 2026: 6 · 2025: 1 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 5 · 2020: 5
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Tampere University Institutional Repository (Tampere University) (submittedVersion, cc-by)
- Funders
- Yrjö Jahnssonin Säätiö
- Aarne Koskelon Säätiö
- Suomen Kulttuurirahasto
- Paavo Nurmen Säätiö
- Pirkanmaan Sairaanhoitopiiri
- Opetushallitus
- Pirkanmaan Rahasto
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- long QT syndrome type 2, hERG, hiPSC-derived cardiomyocytes, arrhythmia susceptibility, adrenaline-induced arrhythmia, calcium transients, asymptomatic mutation carriers, in silico modeling
- MeSH terms
- Adult, Alleles, Cell Aggregation, Female, Humans, Long QT Syndrome, Male, Middle Aged, Models, Biological, Mutation, Ion Channel Gating, Case-Control Studies, Myocytes, Cardiac, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.